ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

Saffiotti Couldn’t Cope With Demands Of National Program, Rauscher Says In Letter To Kennedy

June 11, 1976

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Tobaccos Council Awards New Grants

April 3, 1981

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992